(Q40650033)

22 September 2017

title

Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells (English)

1 reference

22 September 2017

Phenoxodiol – an isoflavone analog – induces apoptosis in chemoresistant ovarian cancer cells (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

30 December 2023

1 reference

intracellular signaling peptides and proteins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730675

30 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

30 December 2023

author name string

Marijke Kamsteeg

1

1 reference

22 September 2017

Thomas Rutherford

2

1 reference

22 September 2017

Eva Sapi

3

1 reference

22 September 2017

Bozena Hanczaruk

4

1 reference

22 September 2017

Shoreh Shahabi

5

1 reference

22 September 2017

Maryann Flick

6

1 reference

22 September 2017

David Brown

7

1 reference

22 September 2017

Gil Mor

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

22 September 2017

https://www.nature.com/articles/1206422.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

https://www.nature.com/articles/1206422

30 December 2023

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

30 December 2023

1 reference

22 September 2017

volume

22

1 reference

22 September 2017

issue

17

1 reference

22 September 2017

page(s)

2611-2620

1 reference

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

The role of the Fas/Fas ligand system in estrogen-induced thymic alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat corpus luteum during apoptosis-mediated luteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Regulation of Fas ligand expression by estrogen in normal ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

The role of c-FLIP in modulation of CD95-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Roles of Fas and Fas ligand during mammary gland remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Commuting the death sentence: how oocytes strive to survive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Pathogenesis of ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

A matter of life and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

1 reference

7 January 2021

Fas antigen-mediated apoptosis of ovarian surface epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206422

7 January 2021

Primary ovarian cancer cultures are resistant to Fas-mediated apoptosis

2

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases

30 December 2023

5

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas

30 December 2023

10

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis

30 December 2023

20

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Expression of Fas-Fas Ligand System Associated with Atresia through Apoptosis in Murine Ovary

30 December 2023

21

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

30 December 2023

22

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

30 December 2023

The death receptors

25

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Apoptosis-based therapies

30 December 2023

27

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP).

30 December 2023

38

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Apoptosis and ovarian function

30 December 2023

39

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues

30 December 2023

42

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206422

30 December 2023

Identifiers

1 reference

Dimensions Publication ID

22 September 2017

1013762965

0 references

1 reference